vs
CVRx, Inc.(CVRX)与泛美白银(USAS)财务数据对比。点击上方公司名可切换其他公司
泛美白银的季度营收约是CVRx, Inc.的1.2倍($19.1M vs $16.0M),CVRx, Inc.净利率更高(-74.5% vs -82.3%,领先7.9%),CVRx, Inc.同比增速更快(4.4% vs -28.0%),CVRx, Inc.自由现金流更多($-9.8M vs $-41.3M)
CVRx, Inc.是一家处于商业化阶段的医疗科技企业,专注于慢性心血管疾病神经调节疗法的研发与商业化,旗舰产品Barostim系统用于治疗心力衰竭和难治性高血压,核心市场覆盖北美、欧洲,服务对常规药物治疗应答不佳的患者。
泛美白银是一家总部位于加拿大的矿业企业,业务布局集中在拉丁美洲,在墨西哥、秘鲁、玻利维亚、阿根廷多国持有运营矿山及其他矿产开发项目,是美洲地区重要的贵金属开采企业。
CVRX vs USAS — 直观对比
营收规模更大
USAS
是对方的1.2倍
$16.0M
营收增速更快
CVRX
高出32.5%
-28.0%
净利率更高
CVRX
高出7.9%
-82.3%
自由现金流更多
CVRX
多$31.5M
$-41.3M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $16.0M | $19.1M |
| 净利润 | $-11.9M | $-15.7M |
| 毛利率 | 86.3% | 34.2% |
| 营业利润率 | -69.8% | — |
| 净利率 | -74.5% | -82.3% |
| 营收同比 | 4.4% | -28.0% |
| 净利润同比 | -12.0% | 2.8% |
| 每股收益(稀释后) | $-0.45 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CVRX
USAS
| Q4 25 | $16.0M | — | ||
| Q3 25 | $14.7M | $19.1M | ||
| Q2 25 | $13.6M | — | ||
| Q1 25 | $12.3M | — | ||
| Q4 24 | $15.3M | — | ||
| Q3 24 | $13.4M | $26.5M | ||
| Q2 24 | $11.8M | — | ||
| Q1 24 | $10.8M | — |
净利润
CVRX
USAS
| Q4 25 | $-11.9M | — | ||
| Q3 25 | $-12.9M | $-15.7M | ||
| Q2 25 | $-14.7M | — | ||
| Q1 25 | $-13.8M | — | ||
| Q4 24 | $-10.7M | — | ||
| Q3 24 | $-13.1M | $-16.2M | ||
| Q2 24 | $-14.0M | — | ||
| Q1 24 | $-22.2M | — |
毛利率
CVRX
USAS
| Q4 25 | 86.3% | — | ||
| Q3 25 | 86.8% | 34.2% | ||
| Q2 25 | 84.3% | — | ||
| Q1 25 | 83.5% | — | ||
| Q4 24 | 83.2% | — | ||
| Q3 24 | 83.2% | 23.6% | ||
| Q2 24 | 83.9% | — | ||
| Q1 24 | 85.0% | — |
营业利润率
CVRX
USAS
| Q4 25 | -69.8% | — | ||
| Q3 25 | -83.5% | — | ||
| Q2 25 | -105.8% | — | ||
| Q1 25 | -108.8% | — | ||
| Q4 24 | -67.0% | — | ||
| Q3 24 | -97.3% | — | ||
| Q2 24 | -118.3% | — | ||
| Q1 24 | -206.4% | — |
净利率
CVRX
USAS
| Q4 25 | -74.5% | — | ||
| Q3 25 | -87.6% | -82.3% | ||
| Q2 25 | -108.4% | — | ||
| Q1 25 | -111.5% | — | ||
| Q4 24 | -69.4% | — | ||
| Q3 24 | -98.0% | -60.9% | ||
| Q2 24 | -118.8% | — | ||
| Q1 24 | -206.0% | — |
每股收益(稀释后)
CVRX
USAS
| Q4 25 | $-0.45 | — | ||
| Q3 25 | $-0.49 | — | ||
| Q2 25 | $-0.57 | — | ||
| Q1 25 | $-0.53 | — | ||
| Q4 24 | $-0.39 | — | ||
| Q3 24 | $-0.57 | — | ||
| Q2 24 | $-0.65 | — | ||
| Q1 24 | $-1.04 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $75.7M | $39.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $39.3M | $50.2M |
| 总资产 | $104.8M | $234.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CVRX
USAS
| Q4 25 | $75.7M | — | ||
| Q3 25 | $85.1M | $39.1M | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $102.7M | — | ||
| Q4 24 | $105.9M | — | ||
| Q3 24 | $100.2M | — | ||
| Q2 24 | $70.4M | — | ||
| Q1 24 | $80.1M | — |
股东权益
CVRX
USAS
| Q4 25 | $39.3M | — | ||
| Q3 25 | $48.1M | $50.2M | ||
| Q2 25 | $57.9M | — | ||
| Q1 25 | $71.1M | — | ||
| Q4 24 | $71.1M | — | ||
| Q3 24 | $65.2M | $53.1M | ||
| Q2 24 | $55.2M | — | ||
| Q1 24 | $66.3M | — |
总资产
CVRX
USAS
| Q4 25 | $104.8M | — | ||
| Q3 25 | $111.3M | $234.7M | ||
| Q2 25 | $119.6M | — | ||
| Q1 25 | $129.6M | — | ||
| Q4 24 | $133.4M | — | ||
| Q3 24 | $127.7M | — | ||
| Q2 24 | $96.0M | — | ||
| Q1 24 | $106.2M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-9.8M | $-12.5M |
| 自由现金流经营现金流 - 资本支出 | $-9.8M | $-41.3M |
| 自由现金流率自由现金流/营收 | -61.3% | -216.5% |
| 资本支出强度资本支出/营收 | 0.4% | 150.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-40.8M | — |
8季度趋势,按日历期对齐
经营现金流
CVRX
USAS
| Q4 25 | $-9.8M | — | ||
| Q3 25 | $-9.7M | $-12.5M | ||
| Q2 25 | $-7.9M | — | ||
| Q1 25 | $-12.8M | — | ||
| Q4 24 | $-8.0M | — | ||
| Q3 24 | $-10.4M | $2.4M | ||
| Q2 24 | $-9.8M | — | ||
| Q1 24 | $-10.9M | — |
自由现金流
CVRX
USAS
| Q4 25 | $-9.8M | — | ||
| Q3 25 | $-10.0M | $-41.3M | ||
| Q2 25 | $-8.0M | — | ||
| Q1 25 | $-12.9M | — | ||
| Q4 24 | $-8.1M | — | ||
| Q3 24 | $-10.4M | $-11.2M | ||
| Q2 24 | $-10.2M | — | ||
| Q1 24 | $-11.8M | — |
自由现金流率
CVRX
USAS
| Q4 25 | -61.3% | — | ||
| Q3 25 | -68.1% | -216.5% | ||
| Q2 25 | -59.2% | — | ||
| Q1 25 | -104.3% | — | ||
| Q4 24 | -52.5% | — | ||
| Q3 24 | -78.1% | -42.2% | ||
| Q2 24 | -86.3% | — | ||
| Q1 24 | -109.7% | — |
资本支出强度
CVRX
USAS
| Q4 25 | 0.4% | — | ||
| Q3 25 | 2.0% | 150.8% | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.3% | 51.2% | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 8.5% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVRX
| US | $14.9M | 93% |
| Other | $1.1M | 7% |
USAS
暂无分部数据